William Riboulet

1.4k total citations
6 papers, 98 citations indexed

About

William Riboulet is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William Riboulet has authored 6 papers receiving a total of 98 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Nephrology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William Riboulet's work include Renal Diseases and Glomerulopathies (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Diabetes and associated disorders (1 paper). William Riboulet is often cited by papers focused on Renal Diseases and Glomerulopathies (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Diabetes and associated disorders (1 paper). William Riboulet collaborates with scholars based in Switzerland, China and United Kingdom. William Riboulet's co-authors include W. Rapp, S. Raab, Agnès Bénardeau, Björn Jacobsen, Thomas P. Singer, Bernd Kuhn, Dominik Hainzl, Johannes D. Aebi, Giorgio Ottaviani and Dominique Burger and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of the American Society of Nephrology and Bioconjugate Chemistry.

In The Last Decade

William Riboulet

5 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Riboulet Switzerland	4	40	29	17	17	10	6	98
Yadi Li China	6	42 1.1×	9 0.3×	10 0.6×	10 0.6×	3 0.3×	15	118
Kathleen V. Compton United States	6	20 0.5×	47 1.6×	4 0.2×	32 1.9×	6 0.6×	7	303
Marine Silva France	8	80 2.0×	43 1.5×	7 0.4×	6 0.4×	13 1.3×	14	202
Akihiko Yoneyama Japan	6	43 1.1×	53 1.8×	4 0.2×	8 0.5×	3 0.3×	13	119
Ashworth Ct	6	42 1.1×	20 0.7×	23 1.4×	11 0.6×	3 0.3×	12	183
Fengmei Xu China	7	69 1.7×	40 1.4×	5 0.3×	4 0.2×	4 0.4×	13	121
Seo Young Jang South Korea	8	84 2.1×	21 0.7×	5 0.3×	4 0.2×	10 1.0×	16	162
И В Медведева Russia	6	50 1.3×	11 0.4×	19 1.1×	6 0.4×	3 0.3×	18	129
Khaled Thabet Egypt	6	68 1.7×	64 2.2×	3 0.2×	7 0.4×	21 2.1×	13	257
Daihong Wang China	6	46 1.1×	3 0.1×	20 1.2×	12 0.7×	3 0.3×	9	142

Countries citing papers authored by William Riboulet

Since Specialization

Citations

This map shows the geographic impact of William Riboulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Riboulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Riboulet more than expected).

Fields of papers citing papers by William Riboulet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Riboulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Riboulet. The network helps show where William Riboulet may publish in the future.

Co-authorship network of co-authors of William Riboulet

This figure shows the co-authorship network connecting the top 25 collaborators of William Riboulet. A scholar is included among the top collaborators of William Riboulet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Riboulet. William Riboulet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Fervenza, Fernando C., Loreto Gesualdo, Gianna Mastroianni Kirsztajn, et al.. (2024). MAJESTY: A Phase 3, Randomized, Open-Label, Active Comparator-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations

2.

Keemink, Janneke, et al.. (2023). Estimating Unbound Drug Concentrations in Simulated Human Lung Fluid: Relevance to Lung Antibiotic PKPD. Molecular Pharmaceutics. 20(7). 3578–3588. 6 indexed citations

3.

Rapp, W., S. Raab, William Riboulet, et al.. (2015). Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin, vimentin, podocin, synaptopodin and WT-1 in acute and chronic rat kidney disease models. Histochemistry and Cell Biology. 145(3). 315–326. 32 indexed citations

4.

Martin, Rainer E., Johannes D. Aebi, Bernd Kuhn, et al.. (2015). Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus Monkeys. Journal of Medicinal Chemistry. 58(20). 8054–8065. 35 indexed citations

5.

Bénardeau, Agnès, et al.. (2013). Animal models of metabolic syndrome and associated co-morbidities. 1(1). 152–155.

6.

Ehrlich, George K., Hanspeter Michel, Theresa Truitt, et al.. (2013). Preparation and Characterization of Albumin Conjugates of a Truncated Peptide YY Analogue for Half-Life Extension. Bioconjugate Chemistry. 24(12). 2015–2024. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact